Compare ASTE & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTE | SDGR |
|---|---|---|
| Founded | 1972 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2020 |
| Metric | ASTE | SDGR |
|---|---|---|
| Price | $45.59 | $17.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $41.00 | $26.25 |
| AVG Volume (30 Days) | 164.8K | ★ 846.9K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $1,368,800,000.00 | $256,951,000.00 |
| Revenue This Year | $8.19 | $23.69 |
| Revenue Next Year | $6.23 | $20.46 |
| P/E Ratio | $22.26 | ★ N/A |
| Revenue Growth | 6.66 | ★ 32.90 |
| 52 Week Low | $29.65 | $15.99 |
| 52 Week High | $50.83 | $28.47 |
| Indicator | ASTE | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 47.32 |
| Support Level | $45.72 | $17.02 |
| Resistance Level | $47.56 | $19.04 |
| Average True Range (ATR) | 1.44 | 0.78 |
| MACD | 0.17 | 0.07 |
| Stochastic Oscillator | 49.62 | 33.00 |
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.